Alnylam Pharmace. buy Chardan Capital
Start price
08.08.23
/
50%
€168.60
Target price
08.08.24
€228.30
Performance (%)
46.56%
End price
09.08.24
€247.10
Summary
This prediction ended on 09.08.24 with a price of €247.10. The BUY prediction by Chardan_Capital for Alnylam Pharmace. saw massive gains of 46.56%. Chardan_Capital has a follow-up prediction for Alnylam Pharmace. where he still thinks Alnylam Pharmace. is a Buy. Chardan_Capital has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Alnylam Pharmace. | 0.118% | 0.118% | 45.419% |
| iShares Core DAX® | 0.650% | 3.212% | 21.634% |
| iShares Nasdaq 100 | 1.650% | 0.322% | 5.422% |
| iShares Nikkei 225® | 1.232% | 1.549% | 15.333% |
| iShares S&P 500 | 1.413% | 0.282% | 3.125% |
Comments by Chardan_Capital for this prediction
In the thread Alnylam Pharmace. diskutieren
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $250.00 price target on the stock.
Ratings data for ALNY provided by MarketBeat
In the thread Trading Alnylam Pharmace.
Die von Chardan_Capital gewählte maximale Laufzeit wurde überschritten
Current prediction by Chardan_Capital for Alnylam Pharmace.
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€236.90
26.02.25
26.02.25
€286.08
26.02.26
26.02.26
42.72%
23.12.25
23.12.25
Stopped prediction by Chardan_Capital for Alnylam Pharmace.
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€229.30
02.05.25
02.05.25
€287.76
02.05.26
02.05.26
47.45%
23.12.25
23.12.25
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€260.20
11.10.24
11.10.24
€274.17
11.10.25
11.10.25
52.23%
12.10.25
12.10.25
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€139.00
16.02.24
16.02.24
€209.30
16.02.25
16.02.25
77.27%
17.02.25
17.02.25